MC

457.75

+0.04%↑

SAF

290.7

+1.25%↑

SANES

8.041

+0.7%↑

BNP

81.86

+0.45%↑

CS.FR

42.15

+1.44%↑

MC

457.75

+0.04%↑

SAF

290.7

+1.25%↑

SANES

8.041

+0.7%↑

BNP

81.86

+0.45%↑

CS.FR

42.15

+1.44%↑

MC

457.75

+0.04%↑

SAF

290.7

+1.25%↑

SANES

8.041

+0.7%↑

BNP

81.86

+0.45%↑

CS.FR

42.15

+1.44%↑

MC

457.75

+0.04%↑

SAF

290.7

+1.25%↑

SANES

8.041

+0.7%↑

BNP

81.86

+0.45%↑

CS.FR

42.15

+1.44%↑

MC

457.75

+0.04%↑

SAF

290.7

+1.25%↑

SANES

8.041

+0.7%↑

BNP

81.86

+0.45%↑

CS.FR

42.15

+1.44%↑

Search

Eurazeo SE

Slēgts

SektorsFinanšu

55 1.2

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

54.35

Max

55.2

Galvenie mērījumi

By Trading Economics

Ienākumi

-325M

Pārdošana

196M

Dividenžu ienesīgums

5.14

Peļņas marža

-166.051

Darbinieki

549

EBITDA

-276M

Rekomendācijas

By TipRanks

Rekomendācijas

Neitrāls

Prognoze 12 mēnešiem

+44.23% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

5.14%

3.86%

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

3.6B

Iepriekšējā atvēršanas cena

53.8

Iepriekšējā slēgšanas cena

55

Ziņu noskaņojums

By Acuity

33%

67%

115 / 535 Rangs Finance

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bullish Evidence

Eurazeo SE Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2024. g. 11. sept. 06:28 UTC

Iegādes, apvienošanās, pārņemšana

EQT Leads $102.5 Million Series A Funding Round in Belgian Radioisotope Producer PanTera

Salīdzinājums

Cenas izmaiņa

Eurazeo SE Prognoze

Cenas mērķis

By TipRanks

44.23% augšup

Prognoze 12 mēnešiem

Vidējais 78.75 EUR  44.23%

Augstākais 100 EUR

Zemākais 55 EUR

Pamatojoties uz 4 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Eurazeo SE — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

4 ratings

2

Pirkt

1

Turēt

1

Pārdot

Tehniskais rādītājs

By Trading Central

62.3 / N/AAtbalsts un pretestība

Īstermiņā

Strong Bullish Evidence

Vidējā termiņā

Bearish Evidence

Ilgtermiņā

Bearish Evidence

Noskaņojums

By Acuity

115 / 535 Rangs Finanšu

Ziņu noskaņojums

Liecība "Buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Virs vidējā

Finanšu rādītāji

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Eurazeo SE

Eurazeo SE is a private equity and venture capital firm specializing in growth capital, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in mid-market and listed public companies. The company invest in equity in the small-mid and Mid-large buyout segments. The firm seeks to invest in medium-sized or large companies, SMEs, high growth companies, and real estate management and investment activities. It does not have any restrictions regarding the sectors in which it invests but prefers to invest in smart cities, services, leisure and mobility, real estate, fintech, investment activities, distribution, industry, luxury, consumer goods, business services, consumer and retail brands, and health sectors. The firm seeks to invest in consumer brands with a focus on beauty, personal care, household care, juvenile products, apparel, wellness, accessories, home, jewellery, leisure, health, fitness, beverage, and food companies based in United States and Europe. It typically invests in companies with a differentiated concept and global growth potential. The firm identifies companies upstream, carefully selecting them primarily from sectors driven by digital transformation and focusing on changes in lifestyle and consumption (mobility, online buying, collaboration models, etc. The firm invests in large properties in need of restructuring; residential, commercial, and office development projects; and companies with real estate assets in Western Europe. It primarily invests in United States, France, Italy, North America and other European countries. It seeks to invest between "50 million ($54.35 million) to "250 million ($271.77 million) in small mid buyout business. It seeks to invest between "25 million ($27.18 million) to "100 million ($108.71 million) in growth business. It seeks to invest between "10 million ($10.82 million) and "40 million ($43.82 million) in the fields of healthcare research. It seeks to invests between equity investment between "1 million ($1.17 million) and "559.01 mil